Stimcell Energetics (STME) Profit After Tax (2011 - 2026)
Stimcell Energetics' (STME) quarterly Profit After Tax came in at -$90566.0 in Q1 2026, up 35.56% year-on-year from -$66810.2 in Q1 2025, and up 70.76% quarter-over-quarter from -$309748.0 in Q4 2025.
Stimcell Energetics (STME) Profit After Tax (2011 - 2026) Analysis & Trends
Stimcell Energetics' Profit After Tax history runs 14 years deep, the most recent figure standing at -$90566.0 for Q1 2026.
- On a quarterly basis, Profit After Tax rose 35.56% year-over-year to -$90566.0 in Q1 2026; TTM through Feb 2026 was -$885245.0, a 91.0% decrease from a year earlier, with the FY2025 full-year figure at -$566293.0, down 308.38% from the prior year.
- Profit After Tax climbed to -$90566.0 in Q1 2026 per STME's latest filing, from -$309748.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $117853.0 in Q1 2024 and bottomed at -$309748.0 in Q4 2025.
- The 5-year median for Profit After Tax is -$131261.0 (2022), against an average of -$126617.4.
- Across the five-year window, Profit After Tax soared 211.87% in 2024 and plunged 296.9% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$142813.0 in 2022, then surged by 57.6% to -$60547.0 in 2023, then sank by 130.41% to -$139508.0 in 2024, then sank by 122.03% to -$309748.0 in 2025, then soared by 70.76% to -$90566.0 in 2026.
- Per Business Quant, the three latest STME Profit After Tax figures stand at -$90566.0 (Q1 2026), -$309748.0 (Q4 2025), and -$265602.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -90,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -90,566.00 |
| Nov 30, 2025 | -309,748.00 |
| Aug 31, 2025 | -265,602.00 |
| May 31, 2025 | -219,329.00 |
| Feb 28, 2025 | -140,537.00 |
| Nov 30, 2024 | -139,508.00 |
| Aug 31, 2024 | -66,919.00 |
| May 31, 2024 | -116,509.00 |
| Feb 29, 2024 | 117,853.00 |
| Nov 30, 2023 | -60,547.00 |
| Aug 31, 2023 | -76,953.00 |
| May 31, 2023 | -80,794.00 |
| Feb 28, 2023 | -105,351.00 |
| Nov 30, 2022 | -142,813.00 |
| Aug 31, 2022 | -154,685.00 |
| May 31, 2022 | -169,226.00 |
| Feb 28, 2022 | -131,261.00 |
| Nov 30, 2021 | -154,478.00 |
| Aug 31, 2021 | -175,083.00 |
| May 31, 2021 | -409,753.00 |